Skip to main content
Clinical Trials/CTRI/2022/11/047337
CTRI/2022/11/047337
Not yet recruiting
Phase 3

A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF VIRECHANA KARMA AND TRUSHNADI LOHA, LEKHANA BASTI AND TRUSHNADI LOHA AND DIET MANAGEMENT IN DYSLIPIDEMIA

DR ASHWINI 0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: E784- Other hyperlipidemia
Sponsor
DR ASHWINI
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
DR ASHWINI

Eligibility Criteria

Inclusion Criteria

  • 1\) Subjects of Dyslipidemia who have Total Cholesterol: 200\-239 mg/dl, Serum Triglycerides:
  • 150\-499 mg/dl, Elevated Low Density Lipoprotein: 100\-189 mg/dl53
  • , Low or Normal High
  • Density Lipoprotein: 35\-59 mg/dl and Very Low Density Lipoprotein: \>30mg/dl.
  • 2\) Patientâ??s having variations in any or all components of Lipid Profile will be taken for studies
  • 3\) Subjects irrespective of gender.
  • 4\) Subjects between the age group 25\-60 years.
  • 5\) Subjects who are fit for Virechana Karma in Virechana intervention group.
  • 6\) Subjects who are fit for Lekhana Basti in Basti intervention group.
  • 7\) Diagnosed i.e., the patients who are already on Statins and fresh cases of Dyslipidemia will be

Exclusion Criteria

  • 1\) Subjects having any systemic disorders which can interfere with the intervention.
  • 2\) Pregnant \& Lactating women.
  • 3\) Alcoholic subjects will be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials